BioSpace News Archive

RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Symmetry Surgical Inc.® (“Symmetry” or the “Company”), completed its previously announced acquisition of the electrosurgical business of Bovie Medical

Technavio analysts forecast the global vitiligo therapeutics market to grow at a CAGR of over 4% during the forecast period, according to their latest market research report.

By genetically manipulating and removing the most common mutant form of the p53 gene that promotes colorectal cancer in humans, an international team of scientists demonstrated that this therapy reduces tumor growth and tissue invasion.

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) (“Liberty Leaf” or the “Company) is pleased to announce the completion of its first CBD research trial on pain medication for dogs.

MedTech Outlook publishes an annual listing of the Top 10 companies that are at the forefront of solving oncology challenges through technology.

Santhera Pharmaceuticals (SIX: SANN) will announce its first half-year financial figures for 2018 and provide a corporate update on Tuesday, September 4, 2018, at 07:00 CEST / 06:00 BST / 01:00 EDT.

Structured Immunity, a biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration.

Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced the appointment of Jonothan Cooil to Vice President of Engineering, Facilities and Health, Safety & Environment. He will report to Almac Group CEO, Alan Armstrong.

Wounded Warrior Project® (WWP) is excited to announce CSX® as presenting sponsor of its new Carry Forward™ 5K fitness challenge.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of K2M Group Holdings, Inc.